Iowa Seed Fund II Invests in Coralville-Based VIDA Diagnostics

VIDA Diagnostics, Inc. (“VIDA”), the leader in precision pulmonary informatics, announced the completion of a $5.1 million Series B round of equity financing. Funding was led by Chartline Capital Partners. Rittenhouse Ventures, Next Level Ventures, Rural Vitality Fund II, Iowa Seed Fund II, and Northern California Investment Fund also participated in the round.

The investment will be used to expand Coralville-based VIDA’s commercialization efforts, hire additional talent, and enhance its clinical software and services. VIDA will advance its industry-leading solutions for pulmonary disease management, including lung cancer, COPD, and asthma.

Click here for full release on PRNewswire.

Testimonial

The counseling and support we received from the EDC team during our start-up years had a huge impact on our success. And now, we continue to benefit from our EDC relationship with ongoing business and sales coaching and the connections that are helping us grow much faster than the rest of our industry. The Creative Corridor is blessed to have such a strong force for spawning new business.

Jeff Quint, Cedar Ridge Vineyards, Winery & Distillery

Connect with EDC

  • Stay in touch

    Contact us

    Entrepreneurial Development Center
    230 2nd St. SE, Suite 212
    Cedar Rapids, IA 52401
    Phone: (319) 369-4955
    Fax: (319) 832-1481

    Events

  • UI Venture School Open Enrollment
  • Innovation EXPO 2017
  • Blog Archive

  • Meet Me at the EXPO: Greg Edwards, WatchPoint Data
  • Top 10 Reasons to Attend EDC’s Annual Meeting April 13th
  • Budgeting for Success
  • International Trade Office Announces FY16 Export Trade Assistance Program
  • EDC Announces New Educational Series
  • Top 10 Reasons to Attend EDC’s Entrepreneur Showcase at Innovation EXPO on Tuesday, October 21st
  • Five common elements of successful crowd funding campaigns
  • Do you know your influencers?
  • Elevator Pitch Sentence Structure
  • Idea vs. Opportunity?
  •